<em>Focus Europe </em>reports Firm’s representation of Goldman Sachs as financial advisor in Bristol-Myers transaction

Focus Europe reports Firm’s representation of Goldman Sachs as financial advisor in Bristol-Myers transaction

Focus Europe noted the Firm’s representation of Goldman, Sachs & Co. as financial adviser to Bristol-Myers Squibb in the sale of Bristol-Myers’ stake in a diabetes-focused joint venture to AstraZeneca valued at US$4.1 billion. The deal was reported to be one of the largest transactions involving targets or acquirers from Europe that were announced between October 2013 and March 2014.

news-detail.inc